Celularity (CELU) Operating Margin Growth (3y) (2023 - 2025)
Powered by 
Analysis
Celularity (CELU) Operating Margin Growth (3y) (2023 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.20 Bn | 9.35 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.03 Bn | 5.03 Bn | - | -101,581.00 |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.35 Bn | 55.72 Mn | 4.62 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.58 Bn | 251.50 Mn | -20,903.00 |
| 5 | uniQure | 2.98 Bn | 2.98 Bn | 5.49 Mn | 179,305.00 |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - | -2.53 Mn |
| 7 | Precigen | 2.38 Bn | 2.38 Bn | 52.17 Mn | 123,643.00 |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | 5,442.00 |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | 1,354.00 |
| 10 | Celularity | 36.65 Mn | 30.48 Mn | -3.27 Mn | -96,094.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -96,094.00 |
| Sep 30, 2025 | -10,759.00 |
| Jun 30, 2025 | -38,714.00 |
| Mar 31, 2025 | 60,939.00 |
| Dec 31, 2024 | -104,095.00 |
| Sep 30, 2024 | -22,660.00 |
| Jun 30, 2024 | 181,186.00 |
| Mar 31, 2024 | 161,874.00 |
| Dec 31, 2023 | -23,096.00 |
| Sep 30, 2023 | -247,841.00 |